<DOC>
	<DOCNO>NCT00406653</DOCNO>
	<brief_summary>The purpose clinical research study learn abatacept improve sign symptom active Crohn 's Disease patient adequate response therapy . The safety treatment also study .</brief_summary>
	<brief_title>A Study Abatacept Patients With Active Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>18 year old Crohn 's Disease least 3 month moderate severely active Crohn 's Disease inadequate response intolerance Crohn 's Disease treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>